(58a) Development of a Plant Generated Therapeutic Made in-Flight to Treat Microgravity Osteopenia
AIChE Annual Meeting
2022
2022 Annual Meeting
Food, Pharmaceutical & Bioengineering Division
Biomolecular Engineering II
Monday, November 14, 2022 - 8:00am to 8:18am
We are producing transgenic lettuce which expresses a fusion protein consisting of PTH [amino acids 1-34] linked with the fragment crystallizable (Fc) domain of human IgG1 via a flexible linker. The Fc component and sequestration of the PTH-Fc within the plant endoplasmic reticulum is intended to increase bioavailability via oral delivery. We constructed a binary vector for expression of this PTH-Fc protein and used it to constitutively produce PTH-Fc in two varieties of transgenic lettuce via Agrobacterium tumefaciens mediated transformation of wild type lettuce. We have successfully generated transgenic (T) plants and screened T1 and T2 generations using a selectable marker and PCR. An extraction protocol coupled with Western blotting has enabled the detection of PTH-Fc in plant extracts by targeting either the PTH or the Fc portions of the fusion protein. An optimized ELISA protocol has been developed to quantify expression levels of PTH-Fc. Preliminary results show an expression level on the order of 65 mg PTH-Fc per kilogram of fresh weight biomass.